[HTML][HTML] Evaluation of the clinical performance of a novel chemiluminescent immunoassay for detection of anticardiolipin and anti-beta2-glycoprotein 1 antibodies in …
S Zhang, Z Wu, P Li, Y Bai, F Zhang, Y Li - Medicine, 2015 - journals.lww.com
Detection of antiphospholipid antibodies represents the first-line approach for diagnosis of
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade …
L Meneghel, A Ruffatti, S Gavasso… - Clinical Chemistry and …, 2015 - degruyter.com
Background: Fully automated chemiluminescence immunoassays (CLIAs) are emerging
technologies for the detection of anti-cardiolipin (aCL) and anti-β2 glycoprotein I (anti …
technologies for the detection of anti-cardiolipin (aCL) and anti-β2 glycoprotein I (anti …
Assessment of diagnostic methods for the detection of anticardiolipin and anti-βeta2 glycoprotein I antibodies in patients under routine evaluation for antiphospholipid …
TB Martins, N Heikal, J Miller, R Willis, RL Schmidt… - Clinica Chimica …, 2018 - Elsevier
Background We assessed the performance characteristics and correlations of the traditional
enzyme-linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CIA) …
enzyme-linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CIA) …
Evaluation of different immunoassays for the detection of antiphospholipid antibodies: report of a wet workshop during the 13th International Congress on …
R Forastiero, E Papalardo, M Watkins, H Nguyen… - Clinica Chimica …, 2014 - Elsevier
Background The performance and standardization of anticardiolipin (aCL) and anti-β 2
glycoprotein I antibodies (aβ 2 GPI) tests for the confirmation of diagnosis of …
glycoprotein I antibodies (aβ 2 GPI) tests for the confirmation of diagnosis of …
[HTML][HTML] Significance of fully automated tests for the diagnosis of antiphospholipid syndrome
K Oku, O Amengual, M Kato, T Bohgaki, T Horita… - Thrombosis …, 2016 - Elsevier
Antiphospholipid antibodies (aPLs) can vary both immunologically and functionally, thus it is
important to effectively and correctly identify their presence when diagnosing …
important to effectively and correctly identify their presence when diagnosing …
Detection of antiphospholipid antibodies by automated chemiluminescence assay
A Capozzi, E Lococo, M Grasso, A Longo… - Journal of …, 2012 - Elsevier
The laboratory diagnosis of antiphospholipid antibody syndrome (APS) requires the
demonstration of antiphospholipid antibodies (aPL) by lupus anticoagulant (LAC) measured …
demonstration of antiphospholipid antibodies (aPL) by lupus anticoagulant (LAC) measured …
[HTML][HTML] The clinical performance of a new chemiluminescent immunoassay in measuring anti-β2 glycoprotein 1 and anti-Cardiolipin antibodies
J Zhou, X Hou, H Zhang, T Wang… - Medical Science Monitor …, 2018 - ncbi.nlm.nih.gov
Background Laboratory criterion is needed for the classification of antiphospholipid
syndrome (APS), which contain anticardiolipin antibodies (aCL) and anti-β2-glycoprotein 1 …
syndrome (APS), which contain anticardiolipin antibodies (aCL) and anti-β2-glycoprotein 1 …
Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome
L Meneghel, A Ruffatti, S Gavasso, M Tonello… - Clinica Chimica …, 2015 - Elsevier
Abstract Background IgG anti-Domain I (anti-DI) β2 Glycoprotein I (β2GPI) antibodies are
associated to thrombotic risk in antiphospholipid syndrome (APS), but their detection is …
associated to thrombotic risk in antiphospholipid syndrome (APS), but their detection is …
Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti‐beta2‐glycoprotein I antibodies in the laboratory diagnosis of the …
F Van Hoecke, L Persijn, AS Decavele… - … journal of laboratory …, 2012 - Wiley Online Library
Introduction Anticardiolipin (aCL) and anti‐β2‐glycoprotein I (aβ2GPI) antibodies are two of
the three laboratory criteria for antiphospholipid syndrome (APS). All assays for …
the three laboratory criteria for antiphospholipid syndrome (APS). All assays for …
Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the …
L Persijn, AS Decavele, S Schouwers, K Devreese - Thrombosis research, 2011 - Elsevier
INTRODUCTION: The laboratory diagnosis of antiphospholipid syndrome (APS) requires the
demonstration of antiphospholipid antibodies (aPL): lupus anticoagulant (LAC) measured …
demonstration of antiphospholipid antibodies (aPL): lupus anticoagulant (LAC) measured …
相关搜索
- antiphospholipid syndrome laboratory diagnosis
- clinical performance antibodies in the diagnosis
- antiphospholipid syndrome anti cardiolipin
- antiphospholipid syndrome clinical performance
- antiphospholipid syndrome beta2 glycoprotein
- clinical performance chemiluminescent immunoassay
- antiphospholipid antibodies chemiluminescence assay
- chemiluminescence immunoassay glycoprotein i antibodies
- antiphospholipid syndrome antibodies in patients
- antiphospholipid syndrome routine evaluation
- laboratory diagnosis beta2 glycoprotein
- antibodies in patients routine evaluation
- antiphospholipid syndrome antibodies in the diagnosis